Hematology/Oncology
NPI
1205130218
Specialty
Hematology/Oncology
Group practices
10
Medicare group memberships
Hospitals
5
Hospital affiliations
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
119,612 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$8.1M
2,495 prescriptions
Company payments, 2025
$3,324
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jehanzeb Riaz was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 27,540 times for 31 patients. In total Jehanzeb Riaz billed 119,612 services in 76 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: -.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 27,540 | 31 | $0.28 | $7,810 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,500 | 11 | $0.11 | $1,191 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,800 | 48 | $15.47 | $105K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,136 | 18 | $0.09 | $102 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 781 | 14 | $0.73 | $570 |
| 99214 Office E&M - Established | Office | 698 | 150 | $89.43 | $62K |
| 99213 Office E&M - Established | Office | 360 | 224 | $62.49 | $22K |
| 96375 Injection Administration | Office | 186 | 20 | $10.95 | $2,037 |
| 96413 Chemotherapy Administration | Office | 171 | 28 | $90.80 | $16K |
| 96365 Intravenous Infusion, Hydration | Office | 140 | 77 | $42.32 | $5,925 |
| 96367 Intravenous Infusion, Hydration | Office | 125 | 19 | $20.26 | $2,532 |
| 99232 Hospital E&M - Subsequent | Facility | 116 | 72 | $58.52 | $6,788 |
| 96372 Injection Administration | Office | 114 | 25 | $10.08 | $1,149 |
| 96417 Chemotherapy Administration | Office | 94 | 14 | $44.90 | $4,221 |
| 99203 Office E&M - New | Office | 76 | 76 | $77.83 | $5,915 |
By year: 2022 $105K for 1,368 services; 2023 $109K for 4,555 services; 2024 $1.7M for 119,612 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 50 | 26 | $8.45 | $423 |
Medicare prescription drug claims, 2024
In 2024, the drug Jehanzeb Riaz prescribed most often to Medicare patients was Anastrozole, with 171 prescriptions and refills. In total Jehanzeb Riaz wrote 2,495 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 171 | 340 | 43 | $1,921 |
| Procrit Epoetin Alfa | 158 | 158 | 47 | $647K |
| Xtandi Enzalutamide | 106 | 106 | 20 | $1.5M |
| Ondansetron Hcl Generic | 101 | 106 | 69 | $1,004 |
| Prednisone Generic | 98 | 142 | 41 | $528 |
| Tamoxifen Citrate Generic | 97 | 159 | 22 | $1,609 |
| Nivestym Filgrastim-Aafi | 89 | 89 | 30 | $296K |
| Prochlorperazine Maleate Generic | 85 | 85 | 63 | $1,324 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 40 | $2,039 |
| Eliquis Apixaban | 70 | 70 | 15 | $41K |
| Lupron Depot Leuprolide Acetate | 70 | 260 | 32 | $533K |
| Abiraterone Acetate Generic | 62 | 62 | Under 11 | $126K |
| Dexamethasone Generic | 60 | 88 | 33 | $1,406 |
| Udenyca Pegfilgrastim-Cbqv | 57 | 57 | 18 | $234K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 55 | 100 | 18 | $766 |
Brand drugs: - claims; generic drugs: 1,506 claims; opioid claims: 157.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jehanzeb Riaz $3,324 ($3,324 in general payments such as food, travel and fees) from 45 companies. The largest payer was Abbvie Inc. with $507.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $507 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $449 |
| Adaptive Biotechnologies Corporation ADPT | 3 | $193 |
| Genentech USA, Inc. ROG.SW | 10 | $181 |
| Pfizer Inc. PFE | 12 | $169 |
| Celgene Corporation BMY | 16 | $148 |
| Genzyme Corporation SNY | 5 | $147 |
| GlaxoSmithKline, LLC. GSK | 6 | $109 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $100 |
| Pharmacosmos Therapeutics Inc. | 4 | $93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.